Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients

D. Mahadevan, Monica Mita, Donald Richards, Edward McClay, Rebecca Suk Heist, A. Kumar, S. Sundararajan, Aung Naing

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science